Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05567003 · ClinicalTrials.gov registry record · Phase 4
Percutaneous Endoluminal Benign Biliary Laser
A Phase 4 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT05567003 is a Phase 4 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 5 participants.
The verdict
NCT05567003, a Phase 4 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study is being done to evaluate the safety and efficacy of Percutaneous transhepatic cholangioscopic (PTCS) laser incision as an ancillary therapy to traditional approaches such as balloon dilation and large drain placement for Benign Biliary Strictures (BBS). Narrowing or blockage of the bile ducts (biliary stricture) is a difficult to treat medical condition that leads to life-threatening complications. Treatment usually involves multiple procedures or surgeries spanned over months or years, and in many cases, leads to the need for a life-long tube that drains bile fluid outside of the body and into a bag. PTCS laser incision is a promising new treatment for bile duct strictures. The procedure is performed by an Interventional Radiologist who uses a tiny camera (endoscope) and a laser through a small hole in the skin to open up the blocked or narrowed duct. This allows bile to flow freely where it is supposed to go (without a tube) so that it does not backup up and cause life-threatening problems. Based on early experience from patients who have had this procedure done, it appears to be safe and effective, and may lead to needing fewer procedures over time, with the possibility of living without a tube or drain. The main goal of this study is to confirm the safety and efficacy of PTCS laser incision in a series of patients with benign biliary strictures who would otherwise receive standard treatment with long-term biliary tube drainage.
Interventions
- PROCEDURE Percutaneous transhepatic cholangioscopic (PTCS) laser incision
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2024-02-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05567003
The ClinicalTrials.gov registry entry for NCT05567003 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous transhepatic cholangioscopic (PTCS) laser incision is the first listed.
NCT05567003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05567003 about?
NCT05567003 is a clinical study titled "Percutaneous Endoluminal Benign Biliary Laser". This study is being done to evaluate the safety and efficacy of Percutaneous transhepatic cholangioscopic (PTCS) laser incision as an ancillary therapy to traditional approaches such as balloon dilation and large drain placement for Benign Biliary Strictures (BBS). Narrowing or blockage of the bile...
What is the current status of trial NCT05567003?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2022-11-01. Estimated completion is 2024-02-05.
What interventions are being tested in trial NCT05567003?
The interventions under investigation include: Percutaneous transhepatic cholangioscopic (PTCS) laser incision (PROCEDURE).
Who is sponsoring clinical trial NCT05567003?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.